PharmaBoardroom

Did You Know? Puerto Rican Pharma Manufacturing

Puerto Rico is home to the manufacturing plants for many of the world's top pharmaceutical and medical device companies, providing a steady stream of…

Takayuki Yamada – General Manager, Santen China

Japanese ophthalmology specialist Santen first established a China affiliate in 2005 and has grown very successfully in the past 14 years. GM of…

Tessie Che – Chairperson & GM, Amaran Biotech, Taiwan

Tessie Che, chairperson & GM of Amaran Biotech shares the story of how she came to lead the company and set its course to become a leading…

Did You Know? Thailand Healthcare & Life Sciences

Thailand is known around the world for its lush landscapes, ancient architecture and breathtaking beaches. The nation receives more than 35 million…

Giuseppe Allocca – Site Leader Vega Baja & Barceloneta…

Giuseppe Allocca, Pfizer’s site leader for its Vega Baja & Barceloneta operations in Puerto Rico, highlights the importance of Pfizer’s…

Big Pharma Adapting to China’s Rapid Regulatory Changes

China’s pharma market is growing at an unprecedented pace and has become a key element of virtually all pharma multinationals’ international…

New York: A Biotech Hub to Rival Boston & California?

Although Boston and California may be more internationally renowned as biotech hubs, New York is fast catching up. Thanks in large part to its strong…

France: AI & The Quest for Life Sciences 4.0

With Minister of the Economy and Finance, Bruno Le Maire, emphasizing the importance of “winning the battle on data” and eccentric mathematician…

French Cell & Gene Therapy: Finding the Funding

France – one of the most influential countries in the development of gene therapy– still stands as a global powerhouse in the field, with…

How Korea Built a World-Class Biosimilars Industry

The nation of South Korea has overtaken many of its regional counterparts to boast a highly impressive biosimilars pipeline. Here, key stakeholders in…

ISU Abxis: Charting a New Direction

ISU Abxis is a biotech company founded in 2001 with a focus on orphan drugs and rare disease. Part of the ISU chaebol, ISU Abxis has leveraged its…

The Three Top Political Issues for Big Pharma

Eurasia Group’s Aditya Bhattacharji and Sarah Hassan identify and unpack the top three political and policy issues that multinational pharmaceutical…

Tagged with M